ENDO: Society Calls for New Look at Hormone Therapy
March 2015, MedPage Today - The risks and benefits of initiating postmenopausal hormone therapy may vary depending on the age of the patient and the length of time since menopause, according to a scientific statement released by the Endocrine Society.
New data indicate that women ages 50 to 59 who start hormone therapy respond differently than women who begin taking hormones after age 60, Richard Santen, MD, of the University of Virginia, said at a press briefing at the society's annual meeting here.
And the length of time since menopause plays a role too, said Santen, who chaired the task force that developed the statement. "If you start a short time after menopause, the risks are different than if you start a long time after menopause."